:

Pradeepa Pushparaj1, Gunilla B Karlsson Hedestam1

  • 1Department of Microbiology, Tumor, and Cell Biology, Karolinska Institutet, SE-171 77 Stockholm, Sweden.

Trends in microbiology
|October 29, 2025
PubMed
概括

流感神经氨基酶 (NA) 是一个有前途的疫苗点,因为它保留了序列. 针对NA的抗体显示受体模仿性,为通用流感疫苗提供了新的策略.